Sphingosylphosphorylcholine inhibits plasma cell differentiation and ameliorates experimental autoimmune encephalomyelitis
IntroductionMultiple sclerosis (MS) is a potentially disabling disease that damages the brain and spinal cord, inducing paralysis of the body. While MS has been known as a T-cell mediated disease, recent attention has been drawn to the involvement of B cells in its pathogenesis. Autoantibodies from...
Main Authors: | Byunghyun Park, Yu Sun Jeong, Wonseok Hu, Mingyu Lee, Ji Cheol Kim, Geon Ho Bae, Yong-Soo Bae, Yoe-Sik Bae |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2023-06-01
|
Series: | Frontiers in Immunology |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fimmu.2023.1151511/full |
Similar Items
-
Inhibition of the immunoproteasome ameliorates experimental autoimmune encephalomyelitis
by: Michael Basler, et al.
Published: (2014-01-01) -
Anticoagulation with warfarin and rivaroxaban ameliorates experimental autoimmune encephalomyelitis
by: Leonie Stolz, et al.
Published: (2017-07-01) -
Immunomodulation Eliminates Inflammation in the Hippocampus in Experimental Autoimmune Encephalomyelitis, but Does Not Ameliorate Anxiety-Like Behavior
by: Pece Kocovski, et al.
Published: (2021-06-01) -
ADAMTS13 ameliorates inflammatory responses in experimental autoimmune encephalomyelitis
by: Kaili Lu, et al.
Published: (2020-02-01) -
Involvement of mTOR signaling in sphingosylphosphorylcholine-induced hypopigmentation effects
by: Jeong Hyo-Soon, et al.
Published: (2011-08-01)